Bavelloni, A.; Piazzi, M.; Ramazzotti, G.; Fiume, R.; Blalock, W.; Faenza, I. PI3Kα-Selective Inhibitor Alpelisib (BYL719), May Be Effective As Anticancer Agents in Rhabdomyosarcoma. Ital J Anat Embryol 2017, 122, 21.